Product Images Emsam
View Photos of Packaging, Labels & Appearance
- Selegiline Structural Formula - image 01
- Figure 1: Side view of EMSAM - image 02
- Figure 2. Kaplan-Meier Estimates of Cumulative Percent of Patients with Relapse (Study 3) - image 03
- Instructions for Use Figure A - image 04
- Instructions for Use Figure C and Figure D - image 05
- Instructions for Use Figure H - image 06
- Instructions for Use Figure E - image 07
- Dosage application 6 mg/24 h - image 08
- Emsam Transdermal 6 mg/24 hour Carton Label - image 09
- Dosage application 9 mg/24 h - image 10
- Emsam Transdermal 9 mg/24 hour Carton Label - image 11
- Dosage application 12 mg/24 h - image 12
- Instructions for Use Figure B - image 13
- Instructions for Use Figure F - image 14
- Instructions for Use Figure G - image 15
- Emsam Transdermal 12 mg/24 hour Carton Label - image 16
Product Label Images
The following 16 images provide visual information about the product associated with Emsam NDC 49502-902 by Viatris Specialty Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Selegiline Structural Formula - image 01
Figure 1: Side view of EMSAM - image 02
This is a product specification that describes the composition of a medical adhesive or drug layer that comes with a backing Filr and release liner. No further information is available for the context or the purpose of the product.*
Figure 2. Kaplan-Meier Estimates of Cumulative Percent of Patients with Relapse (Study 3) - image 03
Instructions for Use Figure A - image 04
This appears to be a list of body parts.*
Instructions for Use Figure C and Figure D - image 05
This appears to be a label or packaging description for an adhesive product that is used in conjunction with medicine. The text mentions a backing on the outside of the adhesive, likely on the opposite side from where the medicine would be applied. However, without further context or information, it is difficult to provide a more detailed description or identify the specific product.*
Instructions for Use Figure H - image 06
Instructions for Use Figure E - image 07
Dosage application 6 mg/24 h - image 08
Emsam Transdermal 6 mg/24 hour Carton Label - image 09
Dosage application 9 mg/24 h - image 10
The text is not available.*
Emsam Transdermal 9 mg/24 hour Carton Label - image 11
This is a product description for Mylan® Selegiline Transdermal System. The product is a prescription-only medication with NDC number 49502-901-30. It comes in a package containing 30 transdermal systems, each releasing 9mg/24h of the active ingredient. The product label warns against eating certain foods and recommends reading the enclosed Medication Guide. The product should only be used for transdermal purposes, and pharmacists should dispense the product with the Medication Guide included. The rest of the text is illegible.*
Dosage application 12 mg/24 h - image 12
This text is describing medical adhesive patches designed for application to various parts of the body, including the upper arm, upper chest, and upper thigh. The patches likely contain medication, and there is a release liner that needs to be removed before application.*
Instructions for Use Figure B - image 13
Instructions for Use Figure F - image 14
Instructions for Use Figure G - image 15
Emsam Transdermal 12 mg/24 hour Carton Label - image 16
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
